Plain-English translation of NCT05183048 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is an early-stage research study testing whether a new imaging scan using a medication called panitumumab can better help doctors locate head and neck cancer tumors before surgery. Researchers want to compare this new scan with a standard scan that is already used in everyday medical practice. The goal is to see if the new approach helps surgeons find and remove cancer more effectively.
Current imaging methods are helpful but not always perfect at detecting all areas of head and neck cancer. This study explores whether the new treatment approach could provide clearer, more detailed images to help doctors identify cancer location more accurately before surgery.
You likely qualify if…
You likely don't qualify if…
You will have one main study visit about one week before your scheduled surgery. During this visit, you will receive a standard imaging scan (PET/MRI) if you haven't already had one, plus an infusion of the study medication through an IV and an injection of a radioactive tracer. The scans help doctors see where your cancer is located. After your surgery, your surgical findings will be compared to what the scans showed to see how well this new imaging approach works.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States